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ABSTRACT
Invasive group A Streptococcus (iGAS) is frequently associated with emm1 isolates, with an
attendant mortality of around 20%. Cases occasionally arise in previously healthy individuals
with a history of upper respiratory tract infection, soft tissue contusion, and no obvious portal
of entry. Using a new murine model of contusion, we determined the impact of contusion on iGAS
bacterial burden and phenotype.
Calibrated mild blunt contusion did not provide a focus for initiation or seeding of GAS that
was detectable following systemic GAS bacteremia, but instead enhanced GAS migration to the
local draining lymph node following GAS inoculation at the same time and site of contusion.
Increased migration to lymph node was associated with emergence of mucoid bacteria, although
was not specific to mucoid bacteria. In one study, mucoid colonies demonstrated a significant
increase in capsular hyaluronan that was not linked to a covRS or rocA mutation, but to a deletion
in the promoter of the capsule synthesis locus, hasABC, resulting in a strain with increased fitness
for lymph node migration.
In summary, in the mild contusion model used, we could not detect seeding of muscle by GAS.
Contusion promoted bacterial transit to the local lymph node. The consequences of contusion-asso-
ciated bacterial lymphatic migrationmay vary depending on the pathogen and virulence traits selected.
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Introduction
Invasive group A Streptococcus (iGAS) infections, such
as necrotizing myositis and fasciitis have been histori-
cally associated with penetrating trauma [1]. Since the
1990s, invasive emm1 (emm/M1) infections have been
reported in healthy individuals who have a history of
blunt, rather than penetrating, trauma [2–4]. A prospec-
tive population-based study showed a significant asso-
ciation between such non-penetrating trauma and iGAS
necrotizing fasciitis (NF), but not GAS cellulitis [5].
Although traumatic injury appears to accelerate iGAS
in some murine models [6,7], it has proved difficult to
demonstrate specific seeding of contused soft tissue in
the setting of systemic infection, and it remains unclear
how infection may arise in the absence of a defined
portal of entry.
The main human reservoir for GAS is within the
human nasopharynx where GAS employ one or more
regulators to undergo alteration of phenotype to
survive. One of the most-studied two component GAS
regulatory systems is CovRS, which is responsible for
regulating 10–15% of the GAS genome, and repressing
the expression of virulence genes such as those of the
hasABC operon that result in expression of hyaluronan
capsule [8]. CovRS plays an important role in the
systemic dissemination of GAS and spontaneous muta-
tions have been demonstrated in hyper-encapsulated
emm1 GAS isolates from spleen during experimental
in vivo infection [9,10].
Few studies have specifically investigated the link
between blunt trauma and the development of GAS NF
through bacteremic seeding. Using an eccentric contrac-
tion model of injury, Hamilton et al, 2006, reported GAS
seeding of moderately but not mildly injured muscle dur-
ing bacteremia, potentially linked to GAS binding of ske-
letal muscle vimentin [6]. To elicit muscle contraction
injury, this model required insertion of electrodes through
the skin, creating a potential transcutaneous portal of entry,
rather than a blunt contusion. Seki et al, 2008 showed that
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mice inoculated intramuscularly with GAS develop a short
illness, then recover and remain healthy for about 20 days,
but then incur sudden death in the presence of an artificial
bruise, elicited by pinching the right hind limbwith forceps
[7]. The method developed on an earlier model, where a
similar delayed deterioration was observed in the absence
of trauma [11]. Interpretation of these findings was limited
by use of uncalibrated trauma and the possibility of non-
specific spread of infection. A key aim of the current
project was to develop a calibrated murine model of
blunt contusion and undertake a systematic study of both
systemic and local (soft tissue) iGAS infection combined
with contusion.
Methods
Bacteria and bacterial methods
GAS strain H584 [12] and all isogenic derivatives were
cultured in Todd-Hewitt broth (THB) (Oxoid) at 37°C
with 5% CO2 for all experiments. H584 is a contemporary
genome-sequenced emm1 clinical blood isolate associated
with a lethal outbreak of iGAS [12] and was selected as it
showed reliable spread to systemic tissues in a mouse
model of lower respiratory tract infection. For in vivo
studies, GAS were cultured overnight, then centrifuged
and washed in sterile PBS twice prior to resuspension to
the required inoculum density. Capsule hyaluronan from
GAS cultured in THB to mid logarithmic growth phase
was quantified as described previously [13] using the
hyaluronan DuoSet ELISA (R&D). For sequencing analy-
sis of mucoid H584 derivatives arising in vivo, streptococ-
cal DNA was extracted then covRS and rocA were
amplified and sequenced using primers described pre-
viously [13,14]. hasABC promoter primers specifically
designed for this work are shown in Supplementary
Table 1. Whole genome sequencing of mucoid isolates
from lymph node and spleen of one mouse was under-
taken using Illumina MiSeq (MRC CSC Core genomics
laboratory, Imperial College London). Raw sequence
reads have been deposited on the short read archive
under the accession numbers: SAMN08125788-
SAMN08125792 (five individual colonies from the
spleen) and SAMN08125793-SAMN08125797 (five indi-
vidual colonies from the lymph node). The short read
sequences were mapped using SMALT (http://www.san
ger.ac.uk/resources/software/smalt/) to the reference
emm1 genome MGAS5005 (Genbank accession number
NC_007297.2) and single nucleotide polymorphisms
(SNPs) were identified. De novo sequences were gener-
ated using SPAdes [15]. Mapping and SNPs over regula-
tory regions and the hasA promoter were manually
checked using Artemis [16].
Mouse models
Adult female FVB/n mice of 20-30 g, aged 6 to 8 weeks
(Charles River UK Ltd) were maintained in individually
HEPA filtered cages with sterile bedding. GLP Mini Fun
Tunnels (Lillico) were provided for environmental enrich-
ment. Food and water were provided ad libitum and the
facility was maintained on a 12 hour light-dark cycle. Mice
were maintained in cage densities between 3–8 mice per
cage depending on individual weights. Mice were anaes-
thetized briefly with isoflurane (4% induction, 2% main-
tenance) for intranasal, intravenous infection, and
contusion experiments. Following non-terminal experi-
ments, mice were allowed to recover from anaesthesia
and return to their cage. Mice were culled if they reached
defined humane end points.
Contusion model
Under general anaesthesia, a modified weight drop
device [17,18] was used to impart a total energy of 156
mJ to the soft tissue of the left hindlimb. Pilot experi-
ments were conducted using two different weights and a
height of 13 cm to produce a mild (125 g) or moderate
(250 g) inflammatory response in groups of 4 mice. The
mild contusion model was used for all subsequent
experiments as it did not require the administration of
opioid analgesia. Control (non-contusion) animals were
anesthetized using isofluorane only.
Infection with contusion models
The effect of contusion on progression of emm1 iGAS
infection was assessed using three routes of infection
that were each initiated at 0 h, 24 h, or 48 h after
contusion (Figure 1). For exploratory experiments,
group sizes of 6 (i.m. and i.v.) or 8 (i.n.) were used.
For substantive studies involving i.m. infection, groups
were increased to 18 using the same protocols.
Lower respiratory tract infection
Following brief isoflurane anaesthesia mice were chal-
lenged intranasally with 1 × 107 – 1 × 108 cfu GAS per
mouse, administered in a volume of 25 μl that is known
to be sufficient to reach the lower respiratory tract [19].
Intravenous infection
Following brief isoflurane anaesthesia mice were
infected with 1–6 x 107 cfu/mouse in a volume of
50 μl via the lateral tail vein [6] and monitored for 24 h.
Local thigh muscle infection
Mice were infected with 1 × 108 cfu in a 50 μl volume by
intramuscular injection into the left thigh and monitored
for 24 h [20]. This model leads to a systemic infection,
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weight loss of approximately 10%, and bacteremia at 24 h
after onset. Mice were monitored for up to 24 h.
Bacterial counts
Thigh muscle tissue (right and left), inguinal lymph
nodes (right and left), liver, spleen, and lungs (respira-
tory model only) were harvested from euthanized
infected mice. The tissue was weighed and 1x
Phosphate buffered saline (PBS) added dependent on
the tissue weight. Tissues were dissociated in sterile PBS
by fine mincing with dissection scissors; all tissues were
subject to homogenization using a sterile plastic rod in
a sterile 1.5 mL microfuge tube followed by vortexing.
Tissue homogenate was serially diluted in PBS and
plated on Columbia blood agar and the number of
colony forming units (cfu) per milligram was deter-
mined. Blood obtained by cardiac puncture was plated
directly on blood agar (5 μl).
Histopathology
Thigh samples were formalin fixed, decalcified, and
paraffin-embedded prior to sectioning and staining
with haematoxylin and eosin (H&E) or Gram-staining
(when tissue infected). Sections were examined by C.S.
(non-blinded) and degree of muscle damage and
inflammation scored using a semi quantitative grading
scheme[21].
Statistics
All statistical analyses were performed with GraphPad
Prism 6.0. Comparison of two datasets was carried out
using an unpaired Mann-Whitney U test or Chi-square
test and three or more data sets were analysed by
Kruskal-Wallis test followed by Dunn’s multiple com-
parison tests. A p-value less than or equal to 0.05 was
considered significant.
Ethics
Animal studies were conducted according to protocols
approved by the UK Home Office in accordance with
the Animals (Scientific Procedures) Act 1986. The pro-
tocols were approved by the local Ethical Review
Process.
Results
Characterization of murine contusion model
To investigate how blunt trauma without a clear portal
of entry can lead to iGAS NF infections, we developed a
novel murine model of contusion using a modified
125 g weight drop device. This delivered a targeted
force of 156 mJ to anaesthetized mice, that resulted in
mild inflammation with no bony injury at the site of
contusion without any skin break. Histopathological
changes in contused tissue comprised mild focal
inflammation of the subcutis with infiltration of neu-
trophils at 24 h, and a mixed inflammatory response of
neutrophils and macrophages at 48 h following injury,
when compared with controls (Figure 2). A pilot study
using a 250 g weight caused moderate myo-degenera-
tive change, inflammatory infiltrates, and occasional
fractures without weight loss or clinical signs
(Supplementary Figure 1); as such, this weight was
not used in subsequent experiments.
Figure 1. Diagram showing timing of contusion – infection model for exploratory studies.
Route of infection and duration of infection initiated at three time points following contusion (0, 24 and 48 hours).
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Failure of GAS to localize to injured tissue during
bacteremia caused by lower respiratory tract or
intravenous infection
It is hypothesized that a low-level bacteraemia, origi-
nating from a GAS respiratory infection, could seed
sites of soft tissue injury and result in the development
of NF. To determine any relation between GAS soft
tissue infection and GAS lower respiratory tract infec-
tion (LRTI) in the context of antecedent contusion,
exploratory studies were conducted in mice intranasally
(i.n.) infected with emm1 GAS at three different time
points (0, 24 and 48 hours) following injury with the
mild contusion model (timing as indicated in Figure 1);
control groups were infected but not injured.
Antecedent contusion did not however enhance specific
seeding of GAS to muscle at the site of trauma follow-
ing LRTI (Table 1). There was also no difference in
overall progression of infection at 24 h after onset of
LRTI between the injury and control groups, based on
the proportion of mice with viable GAS in liver and
spleen (Table 2).
Although GAS were detectable in spleen and liver 24
h after onset of infection suggesting systemic spread,
GAS were not detectable in the blood at the same time
point. We therefore undertook exploratory experiments
using intravenous injection of GAS to model a more
intense or sustained bacteremia. In line with previous
work that reported spread of GAS to injured muscle
6 hours following intravenous infection [6], we also
detected GAS in injured muscle tissue at 24 h following
an intravenous infection. However, importantly, there
was no difference between injured muscle tissue in
comparison to control muscle tissue taken from the
opposite side of individual mice, nor was there any
difference in bacterial counts between injured muscle
tissue from mice subject to contusion and those not
subject to contusion, control mice (Table 3). While
these data confirmed that GAS can seed muscle tissue
from a high cfu bacteremia, the detection of GAS in the
contused muscle tissue was a non-specific result of
bacteremia, and could not be ascribed to antecedent
trauma in this model of contusion. Progression of GAS
Figure 2. Histological features in soft tissue with or without contusion.
Photomicrographs of H&E stained tissue sections 24 and 48 h following contusion. (representative of 12 per group). A. Control
subcutaneous tissue at 24 h. B Focal inflammation in the subcutis of injured leg 24 hours after contusion. Arrow represents the area of
injury with an inflammatory response. C. Control muscle tissue at 48 h D Injured muscle at 48 h after contusion with focal loss of myofibres
and replacement by a mixed inflammatory response of neutrophils and macrophages.
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infection in other tissues was similarly unaffected by
contusion (Table 4).
GAS clearance from muscle is unaffected by
antecedent mild contusion at the same site
As we were unable to detect specific bacteraemic
seeding of contused tissue, we hypothesized that
seeding of injured soft tissue may occur via local,
unrecognized percutaneous introduction of GAS
and could be advanced in some way by antecedent
trauma. In a further set of exploratory experiments,
mice that received mild muscle contusion were
therefore subject to intramuscular infection with
1 × 108 cfu emm1 GAS in the same thigh at 0 h,
24 h and 48 h after contusion; mice were then
monitored for a further 24 h. Controls were GAS-
infected, but did not undergo contusion. The muscle
inflammatory response was similar between mice
that had combined contusion and infection, and
controls that were infected only, with evidence of a
mixed cell infiltrate and muscle cell lysis (Figure 3).
Antecedent or simultaneous contusion did not affect
subsequent GAS burden in injured muscle tissue at
any time point examined (Supplementary
Figure 2A).
GAS transit to local draining lymph node is
augmented by mild contusion at site of infection
Although GAS clearance from thigh muscle was unaf-
fected by antecedent trauma at any of the time points
tested and systemic spread was not augmented by
trauma, there was an increase in GAS bacterial counts
in the draining ipsilateral inguinal lymph node in those
mice subject to simultaneous infection and contusion;
this was not seen where infection was initiated after
contusion. Indeed, delayed infection appeared to result
Table 1. Exploratory study, lower respiratory tract GAS infection
in presence or absence of trauma: muscle data.
Number (%) of mice with viable GAS in
muscle
Injured muscle
(left leg)
Control muscle
(right leg)
Time (h) from defined injury to
infection
Trauma
Group
Control
Group
Trauma
Group
Control
Group
0 0/8 (0%) 0/8
(0%)
0/8 (0%) 0/8 (0%)
24 0/8 (0%) 0/8
(0%)
1/8
(12.5%)
4/8
(50%)
48 1/8
(12.5%)
2/8
(25%)
1/8
(12.5%)
1/8
(12.5%)
n = 8 per group
Table 2. Exploratory study, lower respiratory tract GAS infection in presence or absence of trauma: systemic tissue data.
Number (%) of mice with viable GAS in tissues
Lung Blood Spleen Liver
Time (h) from defined injury to infection Trauma Control Trauma Control Trauma Control Trauma Control
0h 2/8
(25%)
5/8
(62.5%)
1/8
(12.5%)
0/8
(0%)
0/8
(0%)
0/8
(0%)
0/8
(0%)
0/8
(0%)
24h 5/8
(62.5%)
6/8
(75%)
0/8
(0%)
0/8
(0%)
1/8
(12.5%)
3/8
(37.5%)
2/8
(25%)
4/8
(50%)
48h 4/8
(50%)
4/8
(50%)
0/8
(0%)
0/8
(0%)
5/8
(62.5%)
3/8
(37.5%)
4/8
(50%)
2/8
(25%)
n = 8 per group
Table 3. Exploratory study, intravenous infection in presence
and absence of trauma: muscle data.
Number (%) of mice with viable GAS
in muscle
Injured muscle
(left leg)
Control muscle
(right leg)
Time (h) from defined injury to
infection
Trauma
Group
Control
Group
Trauma
Group
Control
Group
0* 2/5
(40%)
2/4
(50%)
1/5
(20%)
1/4
(25%)
24 3/6
(50%)
3/6
(50%)
4/6
(67%)
3/6
(50%)
48** 1/4
(25%)
2/5
(40%)
0/4
(0%)
3/5
(60%)
n = 6/group. * 1/6 in the trauma group and 2/6 in the control (uninjured)
groups reached humane end points prior to end of study. **2/6 in the
trauma group and 1/6 in the control (uninjured) group reached humane
end points prior to end of study
Table 4. Exploratory study, intravenous infection in presence
and absence of trauma: systemic tissue data.
Number (%) of mice with viable GAS in tissues
Blood Spleen Liver
Time (h) from
defined injury to
infection Trauma Control Trauma Control Trauma Control
0* 4/5
(80%)
4/4
(100%)
4/5
(80%)
(3/4)
(75%)
3/5
(60%)
2/4
(50%)
24 3/6
(50%)
4/6
(67%)
5/6
(83%)
5/6
(83%)
4/6
(67%)
4/6
(67%)
48** 4/4
(100%)
5/5
(100%)
4/4
(100%)
5/5
(100%)
2/4
(50%)
5/5
(100%)
n = 6/group* 1/6 in the trauma group and 2/6 in the control (uninjured)
groups reached humane end points prior to end of study.
**2/6 in the trauma group and 1/6 in the control (uninjured) group reached
humane end points prior to end of study
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in protection from lymph node spread (Supplementary
Figure 2B, C, D).
To better understand this phenomenon, we extended
the work to undertake a substantive study of lymphatic
spread following simultaneous GAS infection and con-
tusion. This demonstrated a significant increase in bac-
terial counts in the draining ipsilateral inguinal lymph
node of mice that were infected at the time of contu-
sion injury, in comparison to control mice that were
infected but had not been subject to trauma (Figure 4).
Levels of bacteria in the contralateral inguinal lymph
node were substantially lower than those found in the
ipsilateral draining lymph node. Importantly, no differ-
ence in local thigh muscle bacterial burden was
observed between injured and control animals, under-
lining a specific effect of contusion on the interaction of
GAS with afferent lymphatics or the ipsilateral inguinal
lymph node in these experiments. (Figure 4(a,b))
Although dissemination of GAS to the draining
lymph nodes was increased by simultaneous contusion,
a difference in systemic spread of GAS to spleen or
blood was not detected at 24 h in substantive experi-
ments (Figure 4(c,d)).
Emergence of mucoid isolates in draining lymph
node associated with a deletion in hasabc
promoter
GAS colonies cultured from the ipsilateral inguinal
lymph node, blood and spleen of mice infected intra-
muscularly demonstrated a mucoid phenotype that had
not been observed in the inoculum, inter-mixed with
colonies that were phenotypically unchanged. When
data were analyzed according to colony phenotype,
contusion affected spread of both mucoid and non-
mucoid isolates to the ipsilateral lymph node
(Figure 5(a,b)). Mucoid GAS colony phenotype is
usually ascribed to an increase in hyaluronan capsule
[13,22] and accordingly, a significant difference in
hyaluronan capsule production was observed between
mucoid and non-mucoid colonies cultured from lymph
node (Figure 5(c)). To determine if hypermucoid
strains were accounted for by mutations known to be
selected in vivo, amplicons of covRS and rocA
[13,23,24], were sequenced from 10 mucoid lymph
node colonies, but mutations were not detected. To
further determine the basis for hyper-encapsulation,
DNA from 5 mucoid colonies cultured from spleen,
and 5 mucoid colonies from the draining inguinal
lymph node of a single mouse was extracted, subjected
to whole genome sequencing, and compared with the
parent strain genome sequence. 5/5 mucoid isolates
from spleen showed a single nucleotide polymorphism
(SNP) in covR resulting in a base and amino acid
change, ACC (threonine) to CCC (proline) occurring
at codon 65 (out of 228). However, in 5/5 mucoid
colonies obtained from the ipsilateral lymph node, a
213bp deletion in the promoter of the hasABC operon
was detected, in a region incorporating the recently
described P2 promoter region[25], hasS region, and
one CovR DNA binding site (Figure 5(d)). Compared
to the parental strain, no other SNPs were identified in
either the colonies from the spleen or the lymph node.
The encapsulated phenotype of the hasABC P2 mutant
emm1 derivative was stable on passage and distinct
from the parent strain (Figure 5(e,f)).
HasABC P2 promoter variant GAS demonstrates
enhanced transit to draining lymph node.
Emergence of the hyper-encapsulated P2 variant was
detected in the 5 mucoid isolates cultured from the
draining inguinal lymph node, but not spleen, of a
single mouse and was detected 24 h after initiation
of an intramuscular infection. This raised the possi-
bility that spread to the lymphatic system had
resulted in a selective pressure that favoured
enhanced capsule expression, or that the P2 variant
Figure 3. Histological features in soft tissue are similar following infection without or with contusion.
H & E stained tissue sections following GAS thigh muscle infection. A Photomicrograph of GAS-infected thigh tissue 24 h after infection
without contusion. B Photomicrograph of GAS-infected thigh tissue 24 h after contusion and GAS infection. Both sections show multifocal
mixed inflammatory cell infiltrate with slight myodegeneration and cell lysis. Some haemorrhage is seen in A.
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had enhanced ability to reach the lymph node,
either because of reduced clearance in the thigh
muscle, or by enhanced affinity for afferent lympha-
tics, linked to the known hyaluronan interaction
with Lymphatic Vascular Endothelial receptor
(LYVE)-1[22]. We therefore compared the ability
of the P2 variant and the parent emm1 GAS strain
to reach the ipsilateral inguinal lymph node 3 h
after intramuscular infection, in order to focus on
afferent lymphatic spread alone, and to reduce the
possibility that spread via the systemic (blood) cir-
culation would occur. The data unequivocally
demonstrated that, despite an equivalent bacterial
burden in the thigh muscle, the P2 mutant had an
intrinsically enhanced ability to reach or be retained
in the draining inguinal lymph node, and also
demonstrated enhanced dissemination to spleen at
that time point (Figure 6).
Discussion
Group A Streptococcus (GAS) is widely believed to seed
contused tissue after blunt trauma injury [3,6,7]. Using
a model of blunt injury with no external skin break, we
were unable to demonstrate seeding of an invasive
emm1 isolate to injured muscle tissue using two models
of systemic infection. Furthermore, recent contusion
did not affect GAS clearance in muscle at the site of
contusion when a local infection was initiated at the
same site. Instead, the contusion enhanced transit of
GAS bacteria to the locally draining lymph node.
Although there was no enhancement of bacterial spread
beyond this point, it is conceivable that, if infection had
occurred with a more virulent strain, or allowed to
progress further, systemic dissemination may have
been more rapid. Finally, although shown only once,
spread to the locally draining lymph node was
Figure 4. Quantification of GAS in different tissues following simultaneous contusion and local intramuscular GAS infection.
Mice were infected i.m. with emm1 GAS with or without simultaneous contusion to same limb under anaesthetic. GAS clearance was
measured 24h following infection in (A) Thigh muscle; (B) Draining ipsilateral inguinal lymph node (black) and contralateral inguinal lymph
node (grey); (C) Spleen (D) Blood. n = 18/group for substantive study (includes data from Supplementary Figure 2) Horizontal bars represent
the median. Significant difference was observed in bacterial load between contusion group and controls in ipsilateral lymph node in contrast
to other tissues (muscle, contralateral lymph node, blood and spleen).NS, non significant difference; ***p < 0.005.
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associated with emergence of a mucoid hyper-encapsu-
lated phenotype that we determined was due to a muta-
tion in the capsule biosynthesis promoter, and this
mutant was shown to have specifically enhanced ability
to reach the locally draining lymph node.
Many commentators have highlighted the role
played by trauma in the development of invasive GAS
infections, particularly necrotizing fasciitis [3,6,7],
although the seeding of injured muscle tissue from
respiratory tract has not been demonstrated experimen-
tally. Previous studies have reported an effect of ante-
cedent trauma on progression of invasive GAS
infection [6,7], although we were unable to confirm
specific seeding of contused tissue in our model.
Unlike previous work, our contusion model used a
reproducible, calibrated method of force, and did not
require skin penetration, although did result in muscle
inflammation.
We systematically examined data from three
routes of infection and three time points using a
clinically relevant emm1 strain. The contusion
applied in the current work was non-severe and we
cannot exclude the possibility that a moderate or
more substantial contusion would promote
bacteremic seeding of contused muscle; nonetheless,
increased force resulted in fractures, as reported by
other investigators [26–28]. As such, the force
applied may be the maximum achievable experimen-
tally. We considered the possibility that the duration
of observation was insufficient to detect specific seed-
ing of contused muscle by GAS. It is possible that
infection with a less virulent strain might permit
more prolonged indolent infection. A pilot study
using a 7 day observation period using the emm1
strain employed in the current study, failed to
demonstrate specific seeding of contused muscle
despite heavy bacteremia following respiratory tract
infection (Supplementary Table 2). GAS necrotizing
myositis and fasciitis are extremely rare events [29]
and it could be that localization of bacteria to injured
muscle occurs too rarely to be detectable experimen-
tally using group sizes that are practical or ethical in
a laboratory setting. Furthermore, there may be addi-
tional as yet unrecognized genetic or other risk fac-
tors that increase risk of NF in humans.
GAS is known to interact with the lymphatic system
as exemplified by well-recognized clinical syndromes
such lymphadenitis and lymphangitis [30]. Recently,
Figure 5. Emergence of hasABC promoter deletion variants during GAS infection in draining inguinal lymph node.
A Number of mucoid colonies and B. non-mucoid colonies in draining inguinal lymph nodes of contusion group compared to control mice
(*p < 0.01). N = 18 per group (sub-analysis from Figure 4(b)). C. Hyaluronan capsule production by mucoid and non-mucoid bacterial
colonies isolated from the draining lymph node n = 10 per group (**p < 0.05). D. Deletion of 213bp (indicated by red dotted line box) in
hasABC promoter region identified in all five hyper-encapsulated colony variants from lymph node. Deleted region includes P2 promoter,
regulator sRNA hasS region, and CovR binding site for the P1 promoter [25,34]. Equivalent position of deletion in completed reference
genome MGAS5005 (NC_007297.2) is indicated as 1,818,451-1818663bp. E. Colony morphology wild type emm1 parent strain and F.
isogenic hasABC P2 deletion mutant strain
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GAS tropism for draining lymph nodes was reported to
be enhanced by a specific interaction between the bac-
terial hyaluronan capsule and the lymphatic vascular
endothelial receptor, LYVE-1 [22]. In the current work,
although trauma did not influence the seeding or pro-
gression of infection within the muscle, contusion
injury did impact on the migration of GAS to the
local draining lymph node. We considered the possibi-
lity that either lymphatic damage or increased hydro-
static pressure may have enhanced lymphatic spread of
bacteria as a direct consequence of the contusion
injury. Compression and transient trauma are known
to promote lymph fluid movement, and compression
techniques are routinely applied in clinical practice to
improve tissue viability in cases of lymphedema [31].
The impact of compression on bacteria or large cells,
such as cancer cells or leukocytes, is unknown. It seems
likely that bacteria such as GAS may be subject to the
same mechanical forces that affect lymphatic fluid. We
undertook LYVE-1 immunohistochemical staining of
control and contused tissues to examine lymphatic
channels but could not reliably detect evidence of
damage.
The impact of lymphatic tropism on outcome of
invasive infection may vary according to the amount
of capsule expressed. Whether transit to the lymph
node is a protective or dangerous effect may depend
on the virulence of the infecting bacterium; for
emm18 GAS, which are highly encapsulated, reduc-
tion of transit to the lymph node was noted to
influence development of early bacteremia, whereas
this effect was not observed for another GAS geno-
type [22].
Hyper-encapsulation of GAS in vivo was recorded
on a number of occasions in the ipsilateral draining
lymph node following contusion, although the effect
of contusion on GAS migration to lymph node was
seen among both mucoid and non-mucoid colonies.
To determine the basis for hyper-encapsulation, in
one experiment, we undertook genome sequencing
Figure 6. Impact of capsule promoter mutation on GASin ipsilateral lymph node.
A – D Intramuscular infection with GAS P2 promoter variant (P2) compared with parent emm1 GAS strain (WT) (n = 6 per group). GAS
colonies were quantified after 3h infection in (A) Infected thigh muscle; (B) Draining inguinal lymph node or contralateral inguinal lymph
node; (C) Spleen; (D) Blood. P2 mutant showed enhanced bacterial load in the draining lymph node compared to parent emm1 GAS strain
and also in spleen at this time point despite similar load in thigh muscle (**p < 0.01). Horizontal lines represent the median.
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of representative isolates from lymph node and
spleen from a single mouse. Although isolates from
the spleen demonstrated a mutation in covR, which
might be predicted from many other studies [9,32],
the hyper-encapsulated GAS variants in the draining
lymph node demonstrated a deletion in the hasABC
promoter which leads to loss of one of the reported
CovR binding sites[25], thereby de-repressing cap-
sule production specifically [25]. The hyper-encap-
sulated promoter mutant strain (P2) had enhanced
fitness with regard to transit to, and/or retention in,
the draining lymph node consistent with the
reported interaction between hyaluronan and the
lymphatic receptor LYVE-1 [22]. The data suggest
that altered GAS capsular hyaluronan content affects
transit to the draining inguinal lymph node regard-
less of the mechanism by which capsule content is
altered. Although it is possible that the P2 mutation
arose de novo during infection, perhaps through
selective pressure from the innate immune system
(as has been reported for covRS mutations) or expo-
sure to LYVE-1 receptors, it is equally possible that
such mutants are present as rare variants within the
injected inoculum; BLAST search did not identify a
similar mutation in existing sequences. We tested
the possibility that the mutation might emerge
again using the same stock of the parent emm1
GAS strain, screening colonies from lymph node
using primers that amplify the hasABC operon,
however this did not occur, nor did the mutation
arise using an alternate emm1 GAS strain. As such,
we must assume that selection of the P2 mutation
was a rare ‘chance’ event, albeit that the findings
were highly informative with regard to the role of
increased capsule in lymphatic spread.
In summary, blunt contusion injury in the mouse
did not result in detectable seeding of GAS follow-
ing systemic infection. This may reflect the rarity of
invasive GAS infection or the need for additional
factors to enhance infection. GAS migration to the
local draining lymph node was increased when a
mild contusion force was applied at the same time
as bacterial inoculation. The findings may be of
relevance not only to contusion injury and compart-
ment syndromes, which are recognized to be asso-
ciated with serious iGAS infections [1,33], but also
to the application of compression bandaging in lym-
phoedema. While this is recognized to enhance lym-
phatic drainage and overall tissue viability in the
lower limb, caution may be required in the context
of a more virulent bacterial infection such as GAS
until it is known whether such bacterial transit
promotes or prevents systemic dissemination.
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